Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Degludec And Liraglutide: 2 Drivers Of Novo Nordisk's Growth
Seeking Alpha
Tue, 11/13/12 - 12:11 pm
Tags:
diabetes, degludec, liraglutide, Novo Nordisk, Victoza
This Week in Biotech: Part 1
Motley Fool
Sun, 11/11/12 - 09:17 am
Tags:
Novartis, Novo Nordisk, Corcept Therapeutics, Biomarin, Sequenom
Novo Aims for Tresiba U.S. Approval in First Half of 2013
Bloomberg
Fri, 11/9/12 - 11:07 am
Tags:
Novo Nordisk, Tresiba, diabetes, degludec, insulin
FDA panel recommends approval of Novo degludec insulin
Reuters
Thu, 11/8/12 - 09:52 pm
Tags:
FDA, advisory panels, Novo Nordisk, degludec, insulin
Why Investors Are Voting Against Novo Nordisk
Motley Fool
Wed, 11/7/12 - 11:55 am
Tags:
Novo Nordisk, FDA, advisory panels, Tresiba, insulin
5 Companies Dominating Diabetes
Motley Fool
Tue, 11/6/12 - 04:21 pm
Tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Sanofi, Novo Nordisk, MannKind
5 Things to Watch This Week in the Health-Care Sector
Motley Fool
Tue, 11/6/12 - 12:28 pm
Tags:
Novartis, Signifor, Novo Nordisk, Tresiba, Ryzodeg, HCA Holdings
FDA staff highlight heart risk with Novo insulin
Reuters
Tue, 11/6/12 - 10:12 am
Tags:
Novo Nordisk, FDA, insulin, degludec
Novo hikes forecast on 62% jump in Victoza sales
Fierce Pharma
Wed, 10/31/12 - 11:14 am
Tags:
Novo Nordisk, guidance
2012's Best Pharmaceutical Stock
Motley Fool
Sun, 10/28/12 - 11:50 am
Tags:
Novo Nordisk
Novo Nordisk says FDA disclosed focus of upcoming panel meeting
The Fly on the Wall
Fri, 10/26/12 - 10:32 am
Tags:
FDA, advisory panels, Novo Nordisk, diabetes, degludec
FDA panel to weigh heart safety of Novo's new insulin
Reuters
Thu, 10/25/12 - 05:33 pm
Tags:
advisory panels, FDA, Novo Nordisk, insulin, diabetes, degludec
Novo Nordisk: Encouraging Pipeline News
Seeking Alpha
Tue, 10/23/12 - 09:13 am
Tags:
Novo Nordisk, Tresiba, Ryzodeg, diabetes
Novo's long-acting insulin degludec takes big step to megamarket status
Fierce Biotech
Fri, 10/19/12 - 12:20 pm
Tags:
degludec, Novo Nordisk, diabetes, insulin, Europe, Tresiba
Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
Seeking Alpha
Tue, 10/9/12 - 09:55 am
Tags:
obesity, Novo Nordisk, Merck, Bristol-Myers Squibb, diabetes, Sanofi
Novo to Hire 1,000 People in 2 Years in Emerging Markets
Bloomberg Businessweek
Fri, 10/5/12 - 12:23 pm
Tags:
emerging markets, diabetes, Novo Nordisk
Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up
Bloomberg
Fri, 10/5/12 - 11:25 am
Tags:
Bristol-Myers Squibb, Novo Nordisk, Amylin, diabetes
NVO's Tresiba Approved in Japan
Yahoo/Zacks
Thu, 10/4/12 - 10:39 am
Tags:
Novo Nordisk, Tresiba, Japan, diabetes
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Seeking Alpha
Wed, 10/3/12 - 10:50 am
Tags:
patents, Bristol-Myers Squibb, Amylin, AstraZeneca, Novo Nordisk, Eli Lilly, Merck
Is Novo Nordisk the Perfect Stock?
Motley Fool
Sat, 09/29/12 - 11:51 am
Tags:
Novo Nordisk

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.